tiprankstipranks
Advertisement
Advertisement

MESO Stock Latest News

Largest borrow rate increases among liquid names
The FlyLargest borrow rate increases among liquid names
9d ago
EVC
RUM
Mesoblast Details April Equity Issuance Moves and Director Share Purchases
PremiumCompany Announcements
Mesoblast Details April Equity Issuance Moves and Director Share Purchases
1M ago
6K
MESO
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
1M ago
RUM
YSS
Mesoblast acquires chimeric antigen receptor platform technology
PremiumThe Fly
Mesoblast acquires chimeric antigen receptor platform technology
1M ago
MESO
Mesoblast receives IND clearance from FDA for Ryoncil trial
PremiumThe Fly
Mesoblast receives IND clearance from FDA for Ryoncil trial
1M ago
MESO
Mesoblast reports $30.3M in Ryoncil sales in March quarter
PremiumThe FlyMesoblast reports $30.3M in Ryoncil sales in March quarter
1M ago
MESO
Mesoblast reports March quarter Ryoncil sales of $30.3M
Premium
The Fly
Mesoblast reports March quarter Ryoncil sales of $30.3M
2M ago
MESO
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
NVS
PEW
Mesoblast Grants New Director Options Following 2025 AGM Approvals
PremiumCompany Announcements
Mesoblast Grants New Director Options Following 2025 AGM Approvals
2M ago
6K
MESO
Mesoblast Discloses Director Gregory George’s Share and ADS Purchases in Early March 2026
PremiumCompany Announcements
Mesoblast Discloses Director Gregory George’s Share and ADS Purchases in Early March 2026
2M ago
6K
MESO
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
KDK
MPT
Mesoblast Earnings Call: Ryoncil Momentum Meets Rising Costs
PremiumCompany Announcements
Mesoblast Earnings Call: Ryoncil Momentum Meets Rising Costs
3M ago
MESO
Mesoblast Sets Webcast to Present Half-Year 2025 Results and Corporate Update
PremiumCompany AnnouncementsMesoblast Sets Webcast to Present Half-Year 2025 Results and Corporate Update
3M ago
6K
MESO
Mesoblast Touts Ryoncil Survival Data, Prepares Adult SR-aGvHD Pivotal Trial
Premium
Company Announcements
Mesoblast Touts Ryoncil Survival Data, Prepares Adult SR-aGvHD Pivotal Trial
3M ago
6K
MESO
Mesoblast Lifts Ryoncil Revenues, Secures Cheaper Credit and Advances Late-Stage Cell Therapy Pipeline
Premium
Company Announcements
Mesoblast Lifts Ryoncil Revenues, Secures Cheaper Credit and Advances Late-Stage Cell Therapy Pipeline
4M ago
6K
MESO
Mesoblast Reports 84% Survival in Early Real‑World Use of Ryoncil for Pediatric SR‑aGvHD
PremiumCompany Announcements
Mesoblast Reports 84% Survival in Early Real‑World Use of Ryoncil for Pediatric SR‑aGvHD
4M ago
6K
MESO
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
4M ago
GDS
MMM
Mesoblast Wins FDA Backing on Pain and Opioid-Reduction Data for Rexlemestrocel-L in Chronic Low Back Pain
PremiumCompany Announcements
Mesoblast Wins FDA Backing on Pain and Opioid-Reduction Data for Rexlemestrocel-L in Chronic Low Back Pain
4M ago
6K
MESO
Mesoblast received FDA feedback on potential BLA for rexlemestrocel-L
PremiumThe Fly
Mesoblast received FDA feedback on potential BLA for rexlemestrocel-L
4M ago
MESO
Mesoblast Trims Option Overhang After Late-2025 Lapse of 1.45 Million Unquoted Options
PremiumCompany AnnouncementsMesoblast Trims Option Overhang After Late-2025 Lapse of 1.45 Million Unquoted Options
4M ago
6K
MESO
Mesoblast Expands Share Capital After Exercise of 6.9 Million Options
Premium
Company Announcements
Mesoblast Expands Share Capital After Exercise of 6.9 Million Options
4M ago
6K
MESO
Mesoblast Lapses 3 Million Unquoted Warrants, Slightly Simplifying Capital Structure
Premium
Company Announcements
Mesoblast Lapses 3 Million Unquoted Warrants, Slightly Simplifying Capital Structure
4M ago
6K
MESO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >